Pseudoprogression
When scans suggest tumor growth that is actually a treatment effect
Quick Facts
- Type: Imaging and treatment-response phenomenon
- Common settings: Brain tumors, immunotherapy-treated cancers
- Key feature: Apparent growth that later stabilizes or shrinks
- Why it matters: Can be mistaken for treatment failure
Overview
Pseudoprogression describes a situation in cancer care where a follow-up scan suggests that a tumor has grown or become more active, when in fact the change is due to the body's response to treatment rather than true tumor growth. Over the following weeks to months, the area stabilizes or shrinks without a change in therapy.
It is most often discussed in two settings: after radiation and chemotherapy for brain tumors such as glioma, and after immunotherapy for various cancers. Recognizing pseudoprogression is important because mistaking it for genuine progression could lead to stopping an effective treatment too soon. It is a description of an imaging pattern, not a disease in itself.
Symptoms
Pseudoprogression is primarily a finding on imaging, and many people have no new symptoms at all. When symptoms do occur, they reflect swelling or inflammation in or around the treated tumor.
- Headache or a feeling of pressure, especially with brain lesions
- Temporary worsening of symptoms that were already present, such as weakness or balance problems
- Fatigue
- In some immunotherapy cases, mild local discomfort or a flare of symptoms before improvement
Because these overlap with true progression, the pattern is confirmed by repeat imaging and the overall clinical picture rather than by symptoms alone.
Causes
Pseudoprogression is caused by the effects of treatment on the tumor and surrounding tissue:
- Radiation and chemotherapy: In brain tumors, treatment can cause inflammation, leaky blood vessels, and swelling that make the area look larger or more enhancing on MRI.
- Immunotherapy: Drugs that activate the immune system can draw immune cells into and around the tumor, temporarily increasing its apparent size before it shrinks.
In each case the underlying mechanism is the treatment working, even though the scan briefly looks worse.
Risk Factors
- Recent radiation combined with chemotherapy for a brain tumor
- Treatment with immune checkpoint inhibitors and similar immunotherapies
- Certain tumor genetic features (for example, MGMT-methylated gliomas more often show this pattern)
- Imaging performed soon after the end of treatment
Diagnosis
Telling pseudoprogression apart from true progression can be challenging and often relies on time and repeat assessment:
- Repeat imaging: Follow-up MRI or CT after a defined interval; stabilization or shrinkage points to pseudoprogression.
- Advanced MRI techniques: Perfusion and spectroscopy can help estimate whether changes are treatment-related.
- PET scans: May help in selected cases.
- Biopsy: Occasionally needed when the distinction remains unclear and would change treatment.
- Specialized response criteria: Oncologists use defined frameworks to interpret early growth after immunotherapy.
Treatment
Because pseudoprogression reflects treatment working, the main approach is careful observation rather than new cancer treatment.
- Continued therapy: If pseudoprogression is suspected and the person is clinically stable, the current treatment is often continued.
- Symptom control: Steroids may be used short-term to reduce brain swelling and related symptoms.
- Close monitoring: Repeat scans confirm whether the area settles.
Decisions are individualized by the oncology team, weighing the scan, symptoms, and the specific cancer and treatment involved.
When to See a Doctor
If you are in cancer treatment, report any new or worsening symptoms to your care team rather than waiting for the next scan. Seek urgent or emergency care for severe headache, repeated vomiting, sudden weakness or numbness, trouble speaking, seizures, or a sudden change in alertness, as these can signal significant swelling or another emergency. Your team will help interpret scan results in the context of how you are doing overall.
Frequently Asked Questions
Does pseudoprogression mean my cancer is getting worse?
No. Pseudoprogression is a temporary, treatment-related change that makes a tumor look larger or more active on a scan even though it is not truly growing. With time it stabilizes or shrinks, which is why doctors use repeat imaging before changing treatment.
How do doctors tell pseudoprogression from real growth?
They use repeat imaging over time, advanced MRI techniques, sometimes PET scans, and your symptoms to judge the pattern. In uncertain cases that would change treatment, a biopsy may be needed. The key clue is that pseudoprogression settles on later scans.
When does pseudoprogression usually happen?
In brain tumors it often appears in the first weeks to a few months after radiation combined with chemotherapy. With immunotherapy it can show up as early apparent growth that later improves. Timing varies by cancer and treatment.
Will my treatment be stopped if pseudoprogression is suspected?
Often not. If you are clinically stable and the team suspects pseudoprogression, they may continue the current treatment and recheck with imaging. The goal is to avoid stopping a therapy that is actually working.
References
- National Cancer Institute (NCI). Tumor response and imaging in cancer treatment.
- American Society of Clinical Oncology (ASCO). Understanding immunotherapy.
- MedlinePlus, U.S. National Library of Medicine. Brain tumor.
- Radiological Society of North America (RSNA). Brain tumor imaging.